Rosenbot
Robotic surgical systems for orthopedic treatments.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
* | N/A | Series B | |
| Total Funding | 000k | ||
Founded in 2017, Rosenbot Technology is a provider of robotic surgery solutions designed to assist in orthopedic procedures. The company, based in Haidian, China, develops systems that feature capabilities such as real-time intraoperative 3D navigation, automatic surgical planning, and fracture reduction operations. These technologies aim to enhance surgeons' capabilities and reduce the limitations associated with minimally invasive surgery.
The company's core business revolves around the development and sale of industrial robot systems, robot body R&D, and hydrogen fuel cell equipment. Rosenbot has a significant focus on research and development, with over 160 R&D personnel and a portfolio of 168 intellectual property rights, including numerous patents for inventions and utility models.
Rosenbot has successfully raised a total of $14.3 million over four funding rounds, with its latest being a Series C round in January 2025. The company has attracted 13 institutional investors, including notable firms like Shenzhen Capital Group, Medtronic China Fund, and Alphax Partners. Its headquarters are located in Beijing, with additional presence in other Chinese cities like Shunde, Shanghai, and Wuhan.
Keywords: surgical robotics, orthopedic surgery, medical devices, robotic surgery systems, 3D navigation, fracture reduction, minimally invasive surgery, surgical automation, medical technology, robotic-assisted surgery, surgical planning, medtech, healthcare robotics, surgical instruments, China medtech, venture capital, Series C, intelligent manufacturing